Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 33.98 Million CAD | -51.14% |
| 2022 | 69.55 Million CAD | 504.61% |
| 2021 | 11.5 Million CAD | -78.77% |
| 2020 | 54.18 Million CAD | 89.27% |
| 2019 | 28.63 Million CAD | -9.79% |
| 2018 | 31.73 Million CAD | 1388.65% |
| 2017 | 2.13 Million CAD | -93.99% |
| 2016 | 35.45 Million CAD | -84.72% |
| 2015 | 232.07 Million CAD | 1337.55% |
| 2014 | -18.75 Million CAD | -454.97% |
| 2013 | 5.28 Million CAD | -91.57% |
| 2012 | 62.65 Million CAD | 306.13% |
| 2011 | -30.39 Million CAD | -172.67% |
| 2010 | 41.82 Million CAD | -46.17% |
| 2009 | 77.7 Million CAD | 480.43% |
| 2008 | 13.38 Million CAD | -80.98% |
| 2007 | 70.38 Million CAD | 296.99% |
| 2006 | -35.72 Million CAD | -137.93% |
| 2005 | 94.19 Million CAD | -24.21% |
| 2004 | 124.29 Million CAD | 104.85% |
| 2003 | 60.67 Million CAD | 220.45% |
| 2002 | 18.93 Million CAD | 152.01% |
| 2001 | -36.4 Million CAD | 38.58% |
| 2000 | -59.27 Million CAD | 62.88% |
| 1999 | -159.7 Million CAD | -344.45% |
| 1998 | 65.33 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 25.89 Million CAD | 97.69% |
| 2024 Q1 | 13.09 Million CAD | 51.93% |
| 2023 Q1 | 11.58 Million CAD | 783.99% |
| 2023 Q4 | 8.62 Million CAD | -27.14% |
| 2023 FY | 33.98 Million CAD | -51.14% |
| 2023 Q3 | 11.83 Million CAD | 506.41% |
| 2023 Q2 | 1.95 Million CAD | -83.15% |
| 2022 Q1 | 4.12 Million CAD | 207.8% |
| 2022 Q4 | -1.69 Million CAD | 60.31% |
| 2022 Q2 | 71.39 Million CAD | 1632.84% |
| 2022 Q3 | -4.26 Million CAD | -105.98% |
| 2022 FY | 69.55 Million CAD | 504.61% |
| 2021 Q1 | 8.32 Million CAD | -52.37% |
| 2021 FY | 11.5 Million CAD | -78.77% |
| 2021 Q2 | 960 Thousand CAD | -88.47% |
| 2021 Q4 | -3.82 Million CAD | -163.25% |
| 2021 Q3 | 6.04 Million CAD | 529.48% |
| 2020 Q3 | 34.46 Million CAD | 1041.95% |
| 2020 Q4 | 17.47 Million CAD | -49.29% |
| 2020 Q2 | -3.65 Million CAD | -161.95% |
| 2020 Q1 | 5.9 Million CAD | -41.46% |
| 2020 FY | 54.18 Million CAD | 89.27% |
| 2019 Q2 | 8.32 Million CAD | 181.44% |
| 2019 Q1 | 2.95 Million CAD | -54.54% |
| 2019 Q4 | 10.08 Million CAD | 38.97% |
| 2019 FY | 28.63 Million CAD | -9.79% |
| 2019 Q3 | 7.25 Million CAD | -12.8% |
| 2018 Q1 | 4.83 Million CAD | -64.57% |
| 2018 FY | 31.73 Million CAD | 1388.65% |
| 2018 Q2 | 11.82 Million CAD | 144.81% |
| 2018 Q3 | 8.57 Million CAD | -27.51% |
| 2018 Q4 | 6.5 Million CAD | -24.1% |
| 2017 Q4 | 13.63 Million CAD | 108.31% |
| 2017 Q1 | 4.94 Million CAD | -79.92% |
| 2017 Q2 | -22.99 Million CAD | -564.81% |
| 2017 FY | 2.13 Million CAD | -93.99% |
| 2017 Q3 | 6.54 Million CAD | 128.46% |
| 2016 FY | 35.45 Million CAD | -84.72% |
| 2016 Q4 | 24.64 Million CAD | 164.6% |
| 2016 Q2 | 4.74 Million CAD | 246.18% |
| 2016 Q3 | 9.31 Million CAD | 96.12% |
| 2016 Q1 | -3.24 Million CAD | -130.8% |
| 2015 FY | 232.07 Million CAD | 1337.55% |
| 2015 Q4 | 10.54 Million CAD | -95.12% |
| 2015 Q2 | -1.51 Million CAD | -122.47% |
| 2015 Q1 | 6.75 Million CAD | -26.64% |
| 2015 Q3 | 216.29 Million CAD | 14348.75% |
| 2014 FY | -18.75 Million CAD | -454.97% |
| 2014 Q4 | 9.2 Million CAD | 253.19% |
| 2014 Q3 | -6.01 Million CAD | 71.23% |
| 2014 Q2 | -20.89 Million CAD | -1874.67% |
| 2014 Q1 | -1.05 Million CAD | 86.43% |
| 2013 Q3 | 4.1 Million CAD | -19.56% |
| 2013 FY | 5.28 Million CAD | -91.57% |
| 2013 Q4 | -7.79 Million CAD | -290.06% |
| 2013 Q2 | 5.1 Million CAD | 32.63% |
| 2013 Q1 | 3.84 Million CAD | -73.7% |
| 2012 Q4 | 14.62 Million CAD | 414.47% |
| 2012 Q2 | 3.67 Million CAD | -92.5% |
| 2012 FY | 62.65 Million CAD | 306.13% |
| 2012 Q1 | 49 Million CAD | 373.82% |
| 2012 Q3 | -4.65 Million CAD | -226.56% |
| 2011 Q3 | -34.38 Million CAD | -213.56% |
| 2011 Q2 | 30.27 Million CAD | 460.71% |
| 2011 FY | -30.39 Million CAD | -172.67% |
| 2011 Q4 | -17.89 Million CAD | 47.95% |
| 2011 Q1 | -8.39 Million CAD | -147.41% |
| 2010 Q4 | 17.7 Million CAD | 227.06% |
| 2010 Q1 | 15.56 Million CAD | -1.03% |
| 2010 FY | 41.82 Million CAD | -46.17% |
| 2010 Q2 | 13 Million CAD | -16.46% |
| 2010 Q3 | 5.41 Million CAD | -58.37% |
| 2009 FY | 77.7 Million CAD | 480.43% |
| 2009 Q1 | 3.65 Million CAD | 181.81% |
| 2009 Q2 | 30.24 Million CAD | 727.02% |
| 2009 Q3 | 28.07 Million CAD | -7.16% |
| 2009 Q4 | 15.72 Million CAD | -43.99% |
| 2008 Q1 | 3.57 Million CAD | -65.85% |
| 2008 FY | 13.38 Million CAD | -80.98% |
| 2008 Q4 | -4.47 Million CAD | -224.06% |
| 2008 Q3 | 3.6 Million CAD | -66.25% |
| 2008 Q2 | 10.67 Million CAD | 198.41% |
| 2007 FY | 70.38 Million CAD | 296.99% |
| 2007 Q3 | 16.22 Million CAD | -42.68% |
| 2007 Q4 | 10.47 Million CAD | -35.43% |
| 2007 Q2 | 28.3 Million CAD | 84.23% |
| 2007 Q1 | 15.36 Million CAD | 131.52% |
| 2006 Q2 | -2.35 Million CAD | -117.19% |
| 2006 Q4 | -48.74 Million CAD | -3043.48% |
| 2006 Q1 | 13.71 Million CAD | -39.63% |
| 2006 Q3 | 1.65 Million CAD | 170.23% |
| 2006 FY | -35.72 Million CAD | -137.93% |
| 2005 Q2 | 25.01 Million CAD | 39.47% |
| 2005 Q1 | 17.93 Million CAD | -69.56% |
| 2005 FY | 94.19 Million CAD | -24.21% |
| 2005 Q3 | 28.75 Million CAD | 14.95% |
| 2005 Q4 | 22.72 Million CAD | -20.96% |
| 2004 Q1 | 28.33 Million CAD | 67.62% |
| 2004 Q4 | 58.9 Million CAD | 200.37% |
| 2004 Q3 | 19.61 Million CAD | 6.92% |
| 2004 FY | 124.29 Million CAD | 104.85% |
| 2004 Q2 | 18.34 Million CAD | -35.28% |
| 2003 Q1 | 17.87 Million CAD | 0.0% |
| 2003 FY | 60.67 Million CAD | 220.45% |
| 2003 Q3 | 13.76 Million CAD | 13.53% |
| 2003 Q4 | 16.9 Million CAD | 22.82% |
| 2003 Q2 | 12.12 Million CAD | -32.17% |
| 2002 FY | 18.93 Million CAD | 152.01% |
| 2001 FY | -36.4 Million CAD | 38.58% |
| 2000 FY | -59.27 Million CAD | 62.88% |
| 1999 FY | -159.7 Million CAD | -344.45% |
| 1998 FY | 65.33 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.73 Million USD | 416.553% |
| Arem Pacific Corporation | -53.66 Thousand USD | 63421.283% |
| Assisted 4 Living, Inc. | -118.27 Thousand USD | 28831.832% |
| BioCorRx Inc. | -3.76 Million USD | 1002.118% |
| Bionik Laboratories Corp. | -4.94 Million USD | 787.057% |
| Banyan Corp. | -5.48 Million USD | 719.768% |
| Clearday, Inc. | -14.3 Million USD | 337.505% |
| Dental Patient Care America, Inc. | 8974.00 USD | -378571.718% |
| Quantum Medical Transport, Inc. | 222.84 USD | -15249406.372% |
| Empower Clinics Inc. | -2826.87 USD | 1202206.924% |
| First Choice Healthcare Solutions, Inc. | -8.17 Million USD | 515.874% |
| Selectis Health, Inc. | -3.97 Million USD | 955.758% |
| Ethema Health Corporation | 1.17 Million USD | -2788.155% |
| HealthLynked Corp. | -1.01 Million USD | 3457.232% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.78 Million USD | 1318.792% |
| JRSIS Health Care Corporation | -80.91 Thousand USD | 42098.715% |
| Comjoyful International Company | -20.62 Thousand USD | 164853.224% |
| Medical Facilities Corporation | 18.5 Million USD | -83.657% |
| MedSmart Group Inc. | -76.23 Thousand USD | 44672.988% |
| North America Frac Sand, Inc. | -798.47 Thousand USD | 4355.852% |
| Nova Leap Health Corp. | -1.05 Million USD | 3322.017% |
| Nexteligent Holdings, Inc. | -295.32 Thousand USD | 11606.606% |
| PAO Group, Inc. | 235.5 Thousand USD | -14329.234% |
| Primemd Inc. | 3.14 Million USD | -982.153% |
| Raffles Medical Group Ltd | 68.31 Million USD | 50.255% |
| Ryman Healthcare Limited | 2.85 Million USD | -1090.673% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 802887.621% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -3.96 Million USD | 957.902% |
| Mycotopia Therapies, Inc. | -1.18 Million USD | 2976.547% |
| U.S. NeuroSurgical Holdings, Inc. | -816 Thousand USD | 4264.461% |
| Veltex Corporation | -1.06 Million USD | 3296.606% |
| World Financial Holding Group | -28.42 Thousand USD | 119645.487% |
| Xcelerate Inc. | -2.75 Million USD | 1335.395% |